Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them 02.07.2025 / 18:00 CET/CESTThe issuer is solely responsible for the content of this announcement.Read More

You might also be interested in reading Arvinas Presents Late Breaking, Positive Phase 1 Clinical Data for ARV-102, a PROTAC LRRK2 Degrader, at the 2025 International Congress of Parkinson’s Disease and Movement Disorders®.